ZANTE GREG
Insider CIK 1264949 · VKTX Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| VKTX Viking Therapeutics, Inc. | S Sale | 2026-07-29 | 2026-07-29 | 21,217 | $33.47 | $710.1K | 212,204 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | S Sale | 2026-07-29 | 2026-07-29 | 21,217 | $33.47 | $710.1K | 212,204 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award | 2026-07-28 | 2026-07-29 | 31,667 | — | $0 | 233,421 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award | 2026-07-28 | 2026-07-29 | 31,667 | — | $0 | 233,421 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | S Sale | 2026-01-05 | 2026-01-05 | 1,500 | $32.09 | $48.1K | 189,891 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | S Sale | 2026-01-05 | 2026-01-05 | 10,300 | $34.24 | $352.7K | 191,371 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | S Sale | 2026-01-05 | 2026-01-05 | 13,900 | $33.38 | $464.0K | 201,671 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | S Sale | 2026-01-05 | 2026-01-05 | 31,961 | $32.30 | $1.03M | 215,571 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award deriv | 2026-01-02 | 2026-01-05 | 91,000 | — | $0 | 91,000 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award | 2026-01-02 | 2026-01-05 | 32,049 | — | $0 | 247,532 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award | 2026-01-02 | 2026-01-05 | 41,000 | — | $0 | 215,483 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | S Sale | 2025-10-28 | 2025-10-28 | 6,185 | $35.00 | $216.5K | 173,592 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award | 2025-10-27 | 2025-10-28 | 11,117 | — | $0 | 179,777 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | S Sale | 2025-07-03 | 2025-07-03 | 4,266 | $27.76 | $118.4K | 168,660 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award | 2025-07-02 | 2025-07-03 | 7,667 | — | $0 | 172,926 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | S Sale | 2025-01-06 | 2025-01-06 | 45,609 | $42.69 | $1.95M | 169,959 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | S Sale | 2025-01-06 | 2025-01-06 | 4,700 | $43.32 | $203.6K | 165,259 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award deriv | 2025-01-03 | 2025-01-06 | 37,200 | — | $0 | 37,200 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award | 2025-01-03 | 2025-01-06 | 21,667 | — | $0 | 215,568 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award | 2025-01-03 | 2025-01-06 | 44,533 | — | $0 | 193,901 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | M Exercise deriv | 2024-10-28 | 2024-10-28 | 51,000 | — | $0 | 153,000 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | M Exercise deriv | 2024-10-28 | 2024-10-28 | 26,000 | — | $0 | 0 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | M Exercise deriv | 2024-10-28 | 2024-10-28 | 4,251 | — | $0 | 0 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | M Exercise deriv | 2024-10-28 | 2024-10-28 | 12,750 | — | $0 | 0 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | M Exercise | 2024-10-28 | 2024-10-28 | 12,750 | $7.77 | $99.1K | 199,802 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | M Exercise | 2024-10-28 | 2024-10-28 | 4,251 | $4.68 | $19.9K | 204,053 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | S Sale | 2024-10-28 | 2024-10-28 | 6,050 | $79.78 | $482.7K | 158,539 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | S Sale | 2024-10-28 | 2024-10-28 | 1,206 | $81.44 | $98.2K | 149,366 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | S Sale | 2024-10-28 | 2024-10-28 | 7,967 | $80.65 | $642.5K | 150,572 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | M Exercise | 2024-10-28 | 2024-10-28 | 26,000 | $5.80 | $150.8K | 230,053 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | S Sale | 2024-10-28 | 2024-10-28 | 15,825 | $78.69 | $1.25M | 164,589 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | S Sale | 2024-10-28 | 2024-10-28 | 23,082 | $77.68 | $1.79M | 180,414 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | S Sale | 2024-10-28 | 2024-10-28 | 9,265 | $76.94 | $712.8K | 203,496 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | S Sale | 2024-10-28 | 2024-10-28 | 18,620 | $75.79 | $1.41M | 212,761 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | S Sale | 2024-10-28 | 2024-10-28 | 49,672 | $74.56 | $3.70M | 231,381 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | M Exercise | 2024-10-28 | 2024-10-28 | 51,000 | $8.52 | $434.5K | 281,053 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | S Sale | 2024-07-30 | 2024-07-31 | 500 | $58.71 | $29.4K | 187,052 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | S Sale | 2024-07-30 | 2024-07-31 | 12,662 | $56.96 | $721.2K | 190,526 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | S Sale | 2024-07-30 | 2024-07-31 | 2,974 | $57.71 | $171.6K | 187,552 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award | 2024-07-29 | 2024-07-31 | 6,667 | — | $0 | 181,521 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award | 2024-07-29 | 2024-07-31 | 21,667 | — | $0 | 203,188 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | M Exercise deriv | 2024-05-03 | 2024-05-03 | 4,249 | — | $0 | 4,251 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | M Exercise deriv | 2024-05-03 | 2024-05-03 | 30,000 | — | $0 | 60,000 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | S Sale | 2024-05-03 | 2024-05-03 | 45,570 | $74.44 | $3.39M | 192,939 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | S Sale | 2024-05-03 | 2024-05-03 | 3,101 | $73.49 | $227.9K | 238,509 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | S Sale | 2024-05-03 | 2024-05-03 | 847 | $76.07 | $64.4K | 174,854 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | M Exercise | 2024-05-03 | 2024-05-03 | 4,249 | $4.68 | $19.9K | 211,610 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | S Sale | 2024-05-03 | 2024-05-03 | 17,238 | $75.49 | $1.30M | 175,701 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | M Exercise | 2024-05-03 | 2024-05-03 | 30,000 | $4.88 | $146.4K | 241,610 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award | 2024-03-27 | 2024-03-27 | 31,667 | — | $0 | 223,971 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | F Tax w/h | 2024-03-27 | 2024-03-27 | 16,610 | $83.34 | $1.38M | 207,361 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award | 2024-03-01 | 2024-03-04 | 31,667 | — | $0 | 212,397 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | F Tax w/h | 2024-03-01 | 2024-03-04 | 20,093 | $85.22 | $1.71M | 192,304 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | F Tax w/h | 2024-01-04 | 2024-01-04 | 13,872 | $18.58 | $257.7K | 195,730 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | S Sale | 2024-01-04 | 2024-01-04 | 15,000 | $17.90 | $268.5K | 180,730 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award deriv | 2024-01-03 | 2024-01-04 | 155,000 | — | $0 | 155,000 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | F Tax w/h | 2024-01-03 | 2024-01-04 | 30,889 | $17.40 | $537.5K | 209,602 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | F Tax w/h | 2024-01-03 | 2024-01-04 | 18,233 | $17.40 | $317.3K | 170,491 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award | 2024-01-03 | 2024-01-04 | 28,334 | — | $0 | 188,724 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award | 2024-01-03 | 2024-01-04 | 70,000 | — | $0 | 240,491 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | M Exercise deriv | 2023-04-17 | 2023-04-18 | 7,500 | — | $0 | 0 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | M Exercise | 2023-04-17 | 2023-04-18 | 7,500 | $13.07 | $98.0K | 156,779 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | S Sale | 2023-04-17 | 2023-04-18 | 7,500 | $20.00 | $150.0K | 149,279 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | M Exercise deriv | 2023-04-12 | 2023-04-13 | 37,447 | — | $0 | 26,000 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | M Exercise deriv | 2023-04-12 | 2023-04-13 | 4,097 | — | $0 | 12,750 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | S Sale | 2023-04-12 | 2023-04-13 | 41,544 | $18.00 | $747.8K | 149,279 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | M Exercise | 2023-04-12 | 2023-04-13 | 4,097 | $7.77 | $31.8K | 190,823 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | M Exercise | 2023-04-12 | 2023-04-13 | 37,447 | $5.80 | $217.2K | 186,726 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | M Exercise deriv | 2023-04-11 | 2023-04-13 | 3,242 | — | $0 | 16,847 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | M Exercise deriv | 2023-04-11 | 2023-04-13 | 30,000 | — | $0 | 90,000 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | M Exercise deriv | 2023-04-11 | 2023-04-13 | 14,553 | — | $0 | 63,447 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | M Exercise deriv | 2023-04-11 | 2023-04-13 | 8,500 | — | $0 | 8,500 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | M Exercise | 2023-04-11 | 2023-04-13 | 3,242 | $7.77 | $25.2K | 152,521 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | M Exercise | 2023-04-11 | 2023-04-13 | 8,500 | $4.68 | $39.8K | 161,021 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | M Exercise | 2023-04-11 | 2023-04-13 | 30,000 | $4.88 | $146.4K | 191,021 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | M Exercise | 2023-04-11 | 2023-04-13 | 14,553 | $5.80 | $84.4K | 205,574 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | S Sale | 2023-04-11 | 2023-04-13 | 56,295 | $18.00 | $1.01M | 149,279 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | M Exercise deriv | 2023-04-03 | 2023-04-03 | 30,911 | — | $0 | 0 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | F Tax w/h | 2023-04-03 | 2023-04-03 | 55,166 | $17.57 | $969.3K | 149,279 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award | 2023-04-03 | 2023-04-03 | 56,667 | — | $0 | 204,445 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | S Sale | 2023-04-03 | 2023-04-03 | 30,911 | $18.00 | $556.4K | 147,778 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | M Exercise | 2023-04-03 | 2023-04-03 | 30,911 | $7.77 | $240.2K | 178,689 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | M Exercise deriv | 2023-03-30 | 2023-04-03 | 32,000 | — | $0 | 0 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | M Exercise deriv | 2023-03-30 | 2023-04-03 | 42,000 | — | $0 | 0 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | M Exercise deriv | 2023-03-30 | 2023-04-03 | 12,250 | — | $0 | 0 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | M Exercise deriv | 2023-03-30 | 2023-04-03 | 7,500 | — | $0 | 0 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | S Sale | 2023-03-30 | 2023-04-03 | 131,029 | $17.00 | $2.23M | 147,778 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | M Exercise | 2023-03-30 | 2023-04-03 | 7,500 | $4.12 | $30.9K | 278,807 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | M Exercise | 2023-03-30 | 2023-04-03 | 12,250 | $4.65 | $57.0K | 271,307 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | M Exercise | 2023-03-30 | 2023-04-03 | 42,000 | $7.69 | $323.0K | 259,057 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | M Exercise | 2023-03-30 | 2023-04-03 | 32,000 | $8.52 | $272.6K | 217,057 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | F Tax w/h | 2023-01-04 | 2023-01-04 | 20,708 | $8.42 | $174.4K | 185,057 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award deriv | 2023-01-03 | 2023-01-04 | 204,000 | — | $0 | 204,000 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | F Tax w/h | 2023-01-03 | 2023-01-04 | 23,933 | $8.52 | $203.9K | 205,765 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award | 2023-01-03 | 2023-01-04 | 90,667 | — | $0 | 229,698 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | F Tax w/h | 2022-12-30 | 2023-01-04 | 19,697 | $9.40 | $185.2K | 139,031 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award | 2022-12-30 | 2023-01-04 | 20,233 | — | $0 | 158,728 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | F Tax w/h | 2022-01-04 | 2022-01-05 | 8,835 | $4.62 | $40.8K | 136,304 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award deriv | 2022-01-03 | 2022-01-05 | 120,000 | — | $0 | 120,000 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award | 2022-01-03 | 2022-01-05 | 53,333 | — | $0 | 145,139 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | F Tax w/h | 2022-01-03 | 2022-01-05 | 3,097 | $4.88 | $15.1K | 91,806 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | F Tax w/h | 2021-09-28 | 2021-09-30 | 2,306 | $6.50 | $15.0K | 94,485 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award | 2021-09-28 | 2021-09-30 | 6,667 | — | $0 | 96,791 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | F Tax w/h | 2021-01-19 | 2021-01-19 | 808 | $6.68 | $5.4K | 89,751 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award deriv | 2021-01-04 | 2021-01-06 | 78,000 | — | $0 | 78,000 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award | 2021-01-04 | 2021-01-06 | 64,667 | — | $0 | 86,563 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award | 2021-01-04 | 2021-01-06 | 6,783 | — | $0 | 93,346 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | F Tax w/h | 2021-01-04 | 2021-01-06 | 2,787 | $5.80 | $16.2K | 90,559 | SEC↗ |